30 closest matches · ranked by relevance
Mask Ventilation · Airway Obstruction Upper · Airway Management
Primary: Expiratory Tidal Volume (Breaths 6-10) — 4.46; 3.21; 3.12; 3.48 ml/kg
Obstructive Sleep Apnea
Primary: Pharyngeal Critical Pressure (Pcrit) — 1.26; -1.42; -1.06 cm H2O — p=.80
Cardiac Arrest
Primary: Number of Patients Alive at 72 Hours After Episode. — 230; 275 Participants
Obesity
Primary: Time to Intubation — 26; 38 seconds — p=<0.001
Mechanically Ventilated Patients Admitted to a MICU
Primary: Endotracheal Tube Displacement Bias Measured by a Novel Device (AirWave) Compared to CXR — -0.06; -0.29; 0.39 cm
Parkinson Disease
Primary: Respiratory Sensitivity — 0.22; 0.22; 0.21; 0.22 scores on a scale / CmH2O — p=<.0001
Airway Management · Intubation, Intratracheal · Laryngoscopy
Primary: Difference in First-pass Intubation Success Rates Before and After SALAD Training — 44; 74 Participants
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants With a Post-bronchodilator FEV1/FVC <=70% Versus Participants With a Postbronchodilator FEV1/FVC >70% — 308; 893 participants
Bronchiolitis · Respiratory Syncytial Virus Infections
Primary: Lung Function — 0.071; -3.179; 0.186; -3.345 Z score — p=0.0020
Laryngeal Masks
Primary: Airway Seal Pressure After Device Placement — 28; 27; 24 cmH2O
Protective Device (Physical Object) · Aerosol Disease · Droplet Spread
Primary: Measuring the Time for Performing an Airway Procedure With or Without the Biocontainment Device. — 46; 37 time (seconds)
Nasal Obstruction
Primary: Improvement in NOSE Score — 54.8 units on a scale — p=<0.0001
Asthma
Primary: Mild Exacerbation Rate (OFF-LABA) (Change From Baseline) — -0.16; 0.04 Exacerbations/Subject/Week
Lung Diseases
Primary: System Usability Scale (SUS) — 44.7 units on a scale
Difficult Airway · Anesthesia; Functional
Primary: Airway Seal Pressure — 30; 30 cmH2O
Sleep Apnea, Obstructive · Hypotonia · Child, Only
Primary: Ability to Tolerate Measured by Percent of Participants With Protocol Goal — 50 percent of participants
Anesthesia Intubation Complication
Primary: Total Time Taken to Complete the Procedure of Awake Intubation — 900; 651 seconds
Intubation
Primary: Intubation Time — 18; 35 seconds
Obstructive Sleep Apnea
Primary: Distribution of Electrode Configurations Resulting in Greatest Retropalatal Expansion Among Cohort Subjects — 7; 3; 3; 2 Participants
Airway Morbidity
Primary: Number of Subjects Who Present With Postoperative Sore Throat — 71; 71; 67 Participants
Anesthesia
Primary: Total Apneic Events /Total Number Requiring Airway Manipulation — 2; 1 Number of airway manipulations
Endotracheal Intubation · Supraglottic Airway
Primary: Duration of Intubation — 30.9; 30.8; 30.17 seconds
COPD · LUNG DISEASES, OBSTRUCTIVE
Primary: Peripheral Airways Resistance (R5-R20) — 0.23; 0.2; 0.16 kPa/l/s
Nasal Obstruction
Primary: Change in Nasal Obstructive Symptom Evaluation (NOSE) Scores From Baseline to 3 Months — -47.6 score on a scale
Asthma
Primary: Change in Airway Reactivity From Baseline (Visit 1) and 4 Weeks (Visit 2) — 3.0; 3.2; 5.3; 4.3 mg/mL
Asthma · COPD · Interstitial Lung Disease
Primary: FEV1 — 3.03; 2.32; 3.18; 2.76 L
Anaesthesia
Primary: Visualization of Larynx With the Airtraq Laryngoscope and Handphone — 30 participants
Healthy · Smokers · Asthma
Primary: Airway Blood Flow Response to Albuterol — 2.85; -1.43; 17.93; 4.03 μl/min/ml
Swallowing Disorder · Aspiration · Long Term Ventilation
Primary: Muscle Strength — 20; 10 participants
Hypoxia
Primary: Time to First Event: Pulse Oximetry at 95%, or Successful Intubation — 106; 169 seconds